Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma

NCT03716856 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Refractory or Relapsed Multiple Myeloma

Interventions

GENETIC: CAR-BCMA T cells
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

First Affiliated Hospital of Zhejiang University

Collaborators

[object Object]